Sort
25,944 grants matching “neurodegeneration”
TAU AND NEURODEGENERATION
$1,207,231Mayo Clinic Coll Of Med, Jacksonville · P01 · FY2000 · AG
Biochemistry, Cellular and Molecular Biology Program
$1,205,140Rachel Green · Johns Hopkins University · T32 · FY2020 · GM
Neuronal Immunity in HIV Dementia
$1,203,934University Of Nebraska Medical Center · P01 · FY2004 · NS
Neuronal Immunity in HIV Dementia
$1,203,933University Of Nebraska Medical Center · P01 · FY2003 · NS
UNDERSTANDING THE ROLE OF TM2D FAMILY GENES IN NOTCH SIGNALING AND ALZHEIMER'S DISEASE
$1,203,750Shinya Yamamoto · Baylor College Of Medicine · RF1 · FY2021 · AG
Understanding the dynamic interactions between tau pathology and microgliamediated inflammation in Alzheimer's Disease
$1,203,102Ajay Gupta · Weill Medical Coll Of Cornell Univ · R01 · FY2023 · AG
Neuronal Immunity in HIV Dementia
$1,202,916University Of Nebraska Medical Center · P01 · FY2005 · NS
Brain Banking Core
$1,202,212Edward Byung-Ha Lee · University Of Pennsylvania · U54 · FY2019 · NS
Boston University Alzheimer's Disease Core Center
$1,202,058Neil W. Kowall · Boston University Medical Campus · P30 · FY2009 · AG
Aging and Parkinson's Disease: Models of Therapeutics and Neurologic Comorbidity
$1,201,267Timothy J. Collier · Michigan State University · P50 · FY2010 · NS
Molecular and anatomical characterization of cell types in the aging mouse brain
$1,200,613Hongkui Zeng · Allen Institute · R01 · FY2019 · AG
Mechanistic Analysis of Genetic Modifiers in Parkinson's Disease
$1,200,000Dimitri Krainc · Northwestern University At Chicago · R35 · FY2022 · NS
Mechanistic Analysis of Genetic Modifiers in Parkinson's Disease
$1,200,000Dimitri Krainc · Northwestern University At Chicago · R35 · FY2025 · NS
Mechanistic Analysis of Genetic Modifiers in Parkinson's Disease
$1,200,000Dimitri Krainc · Northwestern University At Chicago · R35 · FY2023 · NS
USP13-MEDIATED DOPAMINERGIC NEURODEGENERATION
$1,200,000The Johns Hopkins University · · FY2021 · Defense Health Agency
Neuroprotective signaling and transcriptional pathways in microglia associated with Alzheimer's disease
$1,199,181Alison M Goate · Icahn School Of Medicine At Mount Sinai · R01 · FY2023 · AG
BIOLOGY OF SPATIOTEMPORAL NITRIC OXIDE GRADIENTS
$1,198,780University Of Wyoming · P20 · FY2003 · RR
Tissue Injury and Inflammation in Multiple Sclerosis
$1,198,234Richard M Ransohoff · Cleveland Clinic Lerner Com-Cwru · P01 · FY2006 · NS
Mechanisms of Autophagy
$1,198,111Richard Youle · National Institute Of Neurological Disorders And Stroke · ZIA · FY2015 · NS
A Systems Approach to Targeting Innate Immunity in AD
$1,197,976Todd E. Golde · University Of Florida · U01 · FY2020 · AG
Aging and Parkinson's Disease: Models of Therapeutics and Neurologic Comorbidity
$1,197,836Timothy J. Collier · Michigan State University · P50 · FY2011 · NS
Regulation And Function Of Retroelements
$1,196,104Henry L. Levin · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2025 · HD
New targeted BDNF nanoparticles for treatment of METH addiction and neurotoxicity
$1,194,659Franco Vitaliano · Exqor Technologies, Inc. · R44 · FY2021 · DA
First-in-human SAD & MAD trials for MW151, a novel Alzheimer's disease drug candidate that attenuates proinflammatory cytokine dysregulation
$1,193,602Linda J Van Eldik · University Of Kentucky · R01 · FY2021 · AG
Biochemistry, Cellular and Molecular Biology Program
$1,191,532Rachel Green · Johns Hopkins University · T32 · FY2019 · GM